• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Matrixx Initiatives Recalls Zicam? Extreme Congestion Relief Due to Contamination with Burkholderia Cepacia (Missouri Health Dept., December 19 2012)

Giuseppe

Emeritus
[Source: Missouri Department of Health, full page: (LINK). Edited.]

December 19, 2012

Matrixx Initiatives Recalls Zicam? Extreme Congestion Relief Due to Contamination with Burkholderia Cepacia



The Missouri Department of Health and Senior Services received information regarding the recall of Zicam? Extreme Congestion Relief nasal gel due to the findings of a bacteria called Burkholderia cepacia.

Burkholderia cepacia poses little medical risk to healthy individuals. However, Burkholderia cepacia in a nasal spray could cause upper airway colonization and secondarily lead to respiratory infections in individuals with a compromised immune system or those with chronic lung conditions, such as cystic fibrosis. The organism is resistant to many antibiotics and may be difficult to eradicate in this sensitive population if an infection occurs.

The product is a non-drip liquid nasal gel used as a nasal decongestant and is packaged in a 0.5 oz. spray bottle contained in an outer carton, bearing NDC number 62750-005-10. The affected Zicam? Extreme Congestion Relief lot is 2J23, Expiration 09/15. The product was distributed to retailers nationwide throughout the United States.

The full recall can be found at http://www.fda.gov/Safety/Recalls/ucm332787.htm.


###
-
------
 
Back
Top